Multidrug Resistance-associated Protein (MRP) Expression is Correlated with Expression of Aberrant p53 Protein in Colorectal Cancer

By Fukushima Y.   Oshika Y.   Tokunaga T.   Hatanaka H.   Tomisawa M.   Kawai K.   Ozeki Y.   Tsuchida T.   Kijima H.   Yamazaki H.   Ueyama Y.   Tamaoki N.   Miura S.   Nakamura M.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 935-938

Elsevier

Access to resources Recommend Favorite

Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats

By        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 524-532

Spandidos Publications

Access to resources Recommend Favorite

Multidrug resistance-associated protein 4 is a determinant of arsenite resistance

By              

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 147-154

Spandidos Publications

Access to resources Recommend Favorite

Comments on: Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer, Fukushima Y, Oshika Y, Tokunaga T, et al., Eur J Cancer 1999, 35, 935-938. Mutant p53 and high expression of MRP are associated in acute myeloblastic leukaemia

By Turzanski J.   Zhu Y.-M.   Pallis M.J.   Russell N.H.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 270-271

Elsevier

Access to resources Recommend Favorite

Function, evolution and structure of multidrug resistance protein (MRP)

By deeley R.G.   Cole S.P.C.  

Seminars in Cancer Biology, Vol. 8, Iss. 3, 1997-06 ,pp. : 193-204

Academic Press

Access to resources Recommend Favorite